Literature DB >> 24169870

High dose of prokinetics for refractory hiccups after chemotherapy or the return to a simple drug.

Esther Uña1, Pilar Alonso.   

Abstract

Hiccups in patients with cancer might be difficult to treat, impacting negatively on the quality of life. Many therapies are available, but they are usually started empirically, and often they are unsuccessful. We report a case of a man with metastatic colon cancer who after the first cycle of chemotherapy developed persistent hiccups refractory to neuroleptics and low dose of metoclopramide. After searching for the potential cause, a high dose of prokinetics was initiated in the hospital and his symptoms disappeared. This case shows how searching for potential causes helps start the right treatment immediately, and therefore it is relevant for the prompt relief from this bothersome symptom. So far, no cases reporting high doses of prokinetics to treat persistent hiccups after chemotherapy have been published. This option should be taken into account when developing hiccups and gastro-oesophageal reflux after chemotherapy, especially if low doses of prokinetics have already been tried.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24169870      PMCID: PMC3822185          DOI: 10.1136/bcr-2013-201028

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Hiccups as an adverse reaction to cancer chemotherapy.

Authors:  Yuichi Takiguchi; Reiko Watanabe; Keiichi Nagao; Takayuki Kuriyama
Journal:  J Natl Cancer Inst       Date:  2002-05-15       Impact factor: 13.506

Review 2.  Nausea, vomiting, and hiccups: a review of mechanisms and treatment.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2010

3.  Stop those hiccups!

Authors:  Gail R Pinczower
Journal:  Anesth Analg       Date:  2007-01       Impact factor: 5.108

4.  A randomized cross-over trial of granisetron and dexamethasone versus granisetron alone: the role of dexamethasone on day 1 in the control of cisplatin-induced delayed emesis.

Authors:  I Sekine; Y Nishiwaki; R Kakinuma; K Kubota; F Hojo; T Matsumoto; H Ohmatsu; M Yokozaki; T Kodama
Journal:  Jpn J Clin Oncol       Date:  1996-06       Impact factor: 3.019

Review 5.  Management of hiccups in the palliative care population.

Authors:  Howard S Smith; Atichat Busracamwongs
Journal:  Am J Hosp Palliat Care       Date:  2003 Mar-Apr       Impact factor: 2.500

Review 6.  Diagnosis and management of hiccups in the patient with advanced cancer.

Authors:  Mark A Marinella
Journal:  J Support Oncol       Date:  2009 Jul-Aug

7.  Metoclopramide in hiccup.

Authors:  N Madanagopolan
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

8.  Oral cisapride for the control of delayed vomiting following high-dose cisplatin.

Authors:  B A Pizzo; K M Pisters; V A Miller; S C Grant; L Baltzer; L Hinckley; M G Kris
Journal:  Support Care Cancer       Date:  1999-01       Impact factor: 3.603

9.  Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.

Authors:  M G Kris; R J Gralla; L B Tyson; R A Clark; C Cirrincione; S Groshen
Journal:  J Clin Oncol       Date:  1989-01       Impact factor: 44.544

10.  Hiccup: mystery, nature and treatment.

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.